SS
TNXP icon

SBI Securities’s Tonix Pharmaceuticals TNXP Stock Holding History

SBI Securities’s Portfolio TNXP Stock Details TNXP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.15K Buy
90
+1
+1% +$13 ﹤0.01% 2758
2026
Q1 		$1.22K Buy
89
+13
+17% +$200 ﹤0.01% 2581
2025
Q4 		$1.19K Sell
76
-120
-61% -$2.21K ﹤0.01% 2584
2025
Q3 		$4.74K Buy
196
+39
+25% +$1.45K ﹤0.01% 2068
2025
Q2 		$5.65K Sell
157
-112
-42% -$2.94K ﹤0.01% 1929
2025
Q1 		$4.81K Buy
269
+231
+608% +$4.68K ﹤0.01% 1918
2024
Q4 		$1.24K Buy
+38
New +$790 ﹤0.01% 2512

Other funds holding TNXP

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
JHC
Jones Hill Capital New York $470M AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
II
Ishara Investments Los Angeles, California $136M AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

SBI Securities's TNXP Position: Q2 2026 in Review

SBI Securities increased its Tonix Pharmaceuticals (TNXP) stake by 1.1% in Q2 2026, buying an estimated $13 and bringing the position to 90 shares worth $1.15K. The position accounts for ﹤0.01% of the portfolio, ranked #2758.

SBI Securities first reported a position in TNXP in Q4 2024 and has held it in 7 quarters since. The position peaked at $5.65K in Q2 2025. 103 funds tracked by Wall St. Rank hold TNXP as of Q2 2026.

  • SBI Securities held 90 shares of Tonix Pharmaceuticals worth $1.15K as of Q2 2026.
  • SBI Securities bought 1 Tonix Pharmaceuticals share in Q2 2026, an estimated $13.
  • Tonix Pharmaceuticals made up ﹤0.01% of SBI Securities's portfolio in Q2 2026, its #2758 holding.
  • SBI Securities first reported a position in Tonix Pharmaceuticals in Q4 2024 and has held it in 7 quarters since.
  • SBI Securities's Tonix Pharmaceuticals position peaked at $5.65K in Q2 2025.
  • 103 funds tracked by Wall St. Rank held Tonix Pharmaceuticals as of Q2 2026.

Based on SBI Securities's 13F filing for Q2 2026, filed 23 Jul 2026.